Skip to main content
Clinical Trials/NCT02090686
NCT02090686CompletedNot Applicable

Efficacy of Pulsatile Cupping in Patients With Chronic Low Back Pain - a Randomized Controlled Study.

Charite University, Berlin, Germany1 site in 1 country110 target enrollmentStarted: March 1, 2014Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
110
Locations
1
Primary Endpoint
Intensity of pain on visual analogues scale

Study Overview

Brief Summary

The purpose of this study is to determine whether pulsatile cupping with a cupping device is effective in the treatment of patients with chronic low back pain compared to no cupping or to minimal cupping.

Study Design

Study Type
Interventional
Allocation
Randomized
Primary Purpose
Treatment
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Male and female, 18-65 years
  • •Chronic low back pain (disease duration > 3 months)
  • •Pain intensity on visual analogue scale at inclusion > 40 mm (0-100 mm scale)
  • •Only pharmacological treatment with NSAID or no treatment in the last 4 weeks
  • •Undersigned informed consent form

Exclusion Criteria

  • •Use of anticoagulants (Phenprocoumon, Heparin)
  • •Coagulopathy
  • •Cupping in the last 6 weeks
  • •Other CAM therapies in the last 12 weeks (e.g. acupuncture)
  • •Physical therapy in the last 12 weeks (e.g. massage, osteopathy)
  • •participation in another study in the last 3 months
  • •Paracetamol allergy or intolerance
  • •Pathological neurological symptoms such as muscular paralysis or paraesthesia due to spinal disc herniation or other causes
  • •Known renal and / or hepatic diseases
  • •Intake of central nervous system-acting analgesics in the last 6 weeks
  • •Applying for early retirement due to low back pain
  • •Severe disease that does not allow participation
  • •No undersigned informed consent form

Arms & Interventions

Pulsatile Cupping

Active Comparator

Intervention: Pulsatile Cupping (Device)

No Intervention

No Intervention

Waiting list

Minimal Cupping

Active Comparator

Intervention: Minimal Cupping (Device)

Outcomes

Primary Outcomes

Intensity of pain on visual analogues scale

Time Frame: 4 weeks

Secondary Outcomes

  • Intensity of pain on visual analogue scale(12 weeks)
  • Back function - FFbH-R-Questionnaire(4 weeks, 12 weeks)
  • Quality of Life - SF 36(4 weeks, 12 weeks)
  • Assessment of perceived effect on Likert Scale(4 weeks, 12 weeks)
  • Intake of paracetamol(4 weeks)
  • Adverse events(week 1- 12)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Benno Brinkhaus

Prof.

Charite University, Berlin, Germany

Study Sites (1)

Loading locations...

Similar Trials